Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial (Q42983908)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2004
edit
Language Label Description Also known as
English
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial
scientific article published on April 2004

    Statements

    Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial (English)
    Franco Felizarta
    Cheryl Smith
    Jidah Slim
    Ruth Berggren
    Russell Goodman
    Lisa Ball
    Mandana Khalili
    Douglas T Dieterich
    Hepatitis Resource Network Clinical Trials Group
    1 April 2004
    464-472

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit